知镜 Cognispect · 医学文献与研究工作台

Application of Epigenetic biomarkers in the precision medicine for sepsis-induced acute lung injury: From risk stratification to targeted therapy.

Wei J, Xiong R, Zhang T, Liang F, Chen J, Zhao Y, Huang Y, Huang Z, Peng C.
iScience · 2026-07-16 · PMID 42519060

文献摘要

Sepsis-induced acute lung injury (SI-ALI) remains a leading cause of mortality in critical care, characterized by complex pathophysiology and substantial patient heterogeneity that challenge conventional diagnostic and therapeutic approaches. Precision medicine, which tailors prevention, diagnosis, and treatment strategies to individual patient characteristics, offers a promising avenue to improve outcomes in this condition. This review focuses on the pivotal role of epigenetic modifications-including DNA methylation, histone modifications, and non-coding RNAs-in the pathogenesis and progression of SI-ALI. We comprehensively summarize recent advances in understanding how these epigenetic mechanisms contribute to disease heterogeneity and influence clinical trajectories. Furthermore, we highlight the emerging potential of epigenetic biomarkers as tools for risk stratification, prognostic evaluation, and guidance of targeted therapeutic interventions in SI-ALI. By integrating current research findings, this article aims to establish a novel theoretical framework and translational direction for the precision management of SI-ALI, ultimately facilitating the development of personalized treatment strategies to address the unmet clinical needs in this critical condition.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。